Show simple item record

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

dc.relation.isnodouble105*
dc.relation.isnodouble119*
dc.relation.isnodouble120*
dc.contributor.authorRussell, Mark D.
dc.contributor.authorDey, Mrinalini
dc.contributor.authorFlint, Julia
dc.contributor.authorDavie, Philippa
dc.contributor.authorAllen, Alexander
dc.contributor.authorCrossley, Amy
dc.contributor.authorFrishman, Margreta
dc.contributor.authorGayed, Mary
dc.contributor.authorHodson, Kenneth
dc.contributor.authorKhamashta, Munther
dc.contributor.authorMoore, Louise
dc.contributor.authorPanchal, Sonia
dc.contributor.authorPiper, Madeleine
dc.contributor.authorReid, Clare
dc.contributor.authorSaxby, Katherine
dc.contributor.authorSchreiber, Karen
dc.contributor.authorSenvar, Naz
dc.contributor.authorTosounidou, Sofia
dc.contributor.authorvan de Venne, Maud
dc.contributor.authorWarburton, Louise
dc.contributor.authorWilliams, David
dc.contributor.authorYee, Chee-Seng
dc.contributor.authorGordon, Caroline
dc.contributor.authorGiles, Ian
dc.contributor.authorBSR Standards, Audit and Guidelines Working Group
dc.date.accessioned2023-05-18T14:22:23Z
dc.date.available2023-05-18T14:22:23Z
dc.date.issued2023-04
dc.identifier.citationRussell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023 Apr 3;62(4):1370-1387. doi: 10.1093/rheumatology/keac558.en_US
dc.identifier.issn1462-0324
dc.identifier.eissn1462-0332
dc.identifier.doi10.1093/rheumatology/keac558
dc.identifier.pmid36318965
dc.identifier.urihttp://hdl.handle.net/20.500.14200/837
dc.description.abstractAn Executive Summary of the British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsen_US
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/pmc10070067/en_US
dc.rightsCreative Commons Attribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectRheumatologyen_US
dc.subjectObstetrics. Midwiferyen_US
dc.subjectPharmacologyen_US
dc.titleExecutive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsen_US
dc.typeGuideline
dc.source.journaltitleRheumatology
rioxxterms.versionVoRen_US
rioxxterms.licenseref.startdate2022-11-02
refterms.dateFCD2025-02-21T11:36:56Z
refterms.versionFCDVoR
dc.contributor.trustauthorPanchal, Sonia
dc.contributor.trustauthorGayed, Mary
dc.contributor.trustauthorTosounidou, Sofia
dc.contributor.trustauthorGayed, Mary
dc.contributor.trustauthorTosounidou, Sofia
dc.contributor.departmentRheumatologyen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationSouth Warwickshire University NHS Foundation Trust; et al.en_US
oa.grant.openaccessnaen_US
dc.identifier.FullTexthttps://westmid.openrepository.com/bitstream/handle/20.500.14200/837/Executive%20Summary%20British%20Society%20for%20Rheumatology%20guideline%20on%20prescribing%20drugs%20in%20pregnancy%20and%20breastfeeding%20immunomodulatory%20anti-rheumatic%20drugs%20and%20corticosteroids%202023.pdf?sequence=2&isAllowed=y


Files in this item

Thumbnail
Name:
Executive Summary British Society ...
Size:
404.6Kb
Format:
PDF
Description:
Main article
Download

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution-NonCommercial 4.0 International
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial 4.0 International